Thursday, June 29, 2017
 
 
Company News: Page (1) of 1 - 05/17/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
HAMILTON Benefit Performance at SHN Orpheum Theatre Raises Nearly $1 Million for Damon Runyon Cancer Research Foundation
Funds to Support Breakthrough Cancer Research
(May 17, 2017)

SAN FRANCISCO, May 17, 2017 /PRNewswire/ -- The Damon Runyon Cancer Research Foundation hosted a benefit performance of the Broadway musical HAMILTON on Tuesday, May 16, 2017, at the SHN Orpheum Theatre in San Francisco, raising almost $1 million for innovative cancer research. The event attracted notable attendees including: Steve Chen, co-founder of YouTube; Chamath Palihapitiya of Social Capital LP, who is also a part-owner of the Golden State Warriors NBA team and an original member of the Facebook management team; and Mary and Steve Swig, The Swig Co.

"We are thankful to the HAMILTON cast and crew for putting on such a wonderful show benefitting our organization and the funding we provide for cutting-edge cancer research," said Lorraine W. Egan, President and CEO of Damon Runyon. "The Bay Area is a leading incubator for cancer research at Stanford, UCSF, UC Santa Cruz, and UC Berkeley. We've invested over $60 million in Bay Area cancer research programs at these institutions and are confident that the newly raised funds will help expedite our path to the next breakthroughs in cancer research. We also thank the members of our Bay Area Committee who helped promote the event and raise our profile in the Bay Area." 

The Damon Runyon Cancer Research Foundation has enjoyed a long and successful relationship with Broadway. The Foundation was created in 1946 when Walter Winchell went on air with an appeal for contributions to fight cancer in memory of his friend Damon Runyon, a New York writer whose works inspired the hit musical Guys & Dolls. The Damon Runyon Broadway Tickets service was started in the 1950s and it's been vital to the success of the Foundation ever since.


About the Damon Runyon Cancer Research Foundation
To accelerate breakthroughs, the Damon Runyon Cancer Research Foundation provides today's best young scientists with funding to pursue innovative cancer research. The Foundation has invested over $327 million and funded nearly 3,600 young scientists, including 12 Nobel Prize winners. 100% of all donations to the Foundation are used to support scientific research.

Contact: Mahdiyyah Muhammad
JConnelly 
646-838-5445
[email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hamilton-benefit-performance-at-shn-orpheum-theatre-raises-nearly-1-million-for-damon-runyon-cancer-research-foundation-300457220.html

SOURCE Damon Runyon Cancer Research Foundation

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Science, Medical, Biology, Cancer,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • Fitness App Market 29.45% CAGR by 2021 Says a New Research Report at ReportsnReports.com
  • Home Healthcare Market Size Expected to Reach $391.41 Bn by 2021: Zion Market Research
  • Knee Implants Market Is Expected To Reach USD 13.5 Bn By 2025, Credence Research
  • C-TAC Launches Campaign to Transform Advanced Care
  • Facial Injectables Market Is Expected To Witness Growth Swiftly, Owing To Advancements In Facial Rejuvenation Procedures & Importance Of Medical Aesthetics Till 2025: Grand View Research, Inc

    Cancer
  • Novartis receives EU approval for first-line use of ZykadiaŽ in ALK-positive advanced non-small cell lung cancer (NSCLC)
  • Pharmaleads Reports Positive Phase I SAD Data with its Dual ENKephalinase Inhibitor (DENKI) PL265 for the Treatment of Neuropathic Pain
  • Low Uptake of Cancer Preventing Human Papillomavirus Vaccine Linked to Lasting Injection Fear Formed in Preschool
  • Community Health Accreditation Partner (CHAP) Announces President and CEO Departure
  • Polymedco, Inc. Acquires U.S. Distribution Rights to the PATHFAST Product Line
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines